Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B)

Saved in:
Bibliographic Details
Published in:International journal of clinical oncology 2022-04, Vol.27 (4), p.823-824
Main Authors: Tsubata, Yukari, Watanabe, Kana, Saito, Ryota, Nakamura, Atsushi, Yoshioka, Hiroshige, Morita, Mami, Honda, Ryoichi, Kanaji, Nobuhiro, Oizumi, Satoshi, Jingu, Daisuke, Nakagawa, Taku, Nakazawa, Kensuke, Mouri, Atsuto, Takeuchi, Susumu, Furuya, Naoki, Akazawa, Yuki, Miura, Kiyotaka, Ichihara, Eiki, Maemondo, Makoto, Morita, Satoshi, Kobayashi, Kunihiko, Isobe, Takeshi
Format: Article
Language:English
Subjects:
Cancer Research
Correction
Medicine
Medicine & Public Health
Oncology
Surgical Oncology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1341-9625
1437-7772
DOI:10.1007/s10147-022-02118-8